Shield Therapeutics PLC (GB:STX)
LSE:STX
Holding GB:STX?
Track your performance easily

Shield Therapeutics (STX) Technical Analysis

16 Followers

Technical Sentiment

Overall Consensus
Neutral
10Bullish
2Neutral
10Bearish
Technical Analysis Consensus
Buy
6Bullish
2Neutral
2Bearish
Moving Average Consensus
Sell
4Bullish
0Neutral
8Bearish
Shield Therapeutics PLC’s (STX) Moving Averages Convergence Divergence (MACD) indicator is <0.01, suggesting Shield Therapeutics PLC is a Buy.
Shield Therapeutics PLC’s (STX) 20-Day exponential moving average is 4.35, while Shield Therapeutics PLC’s (STX) share price is 4p, making it a Sell.
Shield Therapeutics PLC’s (STX) 50-Day exponential moving average is 4.11, while Shield Therapeutics PLC’s (STX) share price is 4p, making it a Sell.

Shield Therapeutics (STX) Pivot Points

Nov 10, 2024, 08:24 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
3.43
3.62
3.83
4.02
4.23
4.42
4.63
Fibonacci
3.62
3.77
3.86
4.02
4.17
4.26
4.42
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Shield Therapeutics (STX) Moving Averages

Nov 10, 2024, 08:24 AM
Period
Simple
Exponential
MA5
4.26Sell
4.19Sell
MA10
4.46Sell
4.31Sell
MA20
4.40Sell
4.35Sell
MA50
4.34Sell
4.11Sell
MA100
3.28Buy
3.73Buy
MA200
3.20Buy
3.98Buy
Shield Therapeutics PLC’s (STX) 10-Day exponential moving average is 4.31, while Shield Therapeutics PLC’s (STX) share price is 4p, making it a Sell.
Shield Therapeutics PLC’s (STX) 100-Day exponential moving average is 3.73, while Shield Therapeutics PLC’s (STX) share price is 4p, making it a Buy.
Shield Therapeutics PLC’s (STX) stock price is 4p and Shield Therapeutics PLC’s (STX) 50-day simple moving average is 4.34, creating a Sell signal.
Shield Therapeutics PLC’s (STX) stock price is 4p and Shield Therapeutics PLC’s (STX) 100-day simple moving average is 3.28, creating a Buy signal.
Shield Therapeutics PLC’s (STX) stock price is 4p and Shield Therapeutics PLC’s (STX) 200-day simple moving average is 3.20, creating a Buy signal.

Shield Therapeutics (STX) Technical Indicators

Nov 10, 2024, 08:24 AM
Name
Value
Implied Action
RSI (14)
42.43
Neutral
STOCH (9,6)
13.48
Buy
STOCHRSI (14)
13.05
Buy
MACD (12,26)
<0.01
Buy
ADX (14)
19.43
Buy
Williams %R
-84.62
Buy
CCI (14)
-126.15
Buy
ATR (14)
0.36
-
Ultimate Oscillator
40.96
Neutral
ROC
-2.44
Sell
Shield Therapeutics PLC’s (STX) Relative Strength Index (RSI) is 42.43, creating a Neutral signal.
Shield Therapeutics PLC’s (STX) Trend Strength Indicator (ADX) is 19.43, creating a Buy signal.
Shield Therapeutics PLC’s (STX) Commodity Channel Index (CCI) is -126.15, creating a Buy signal.
Shield Therapeutics PLC’s (STX) Price Rate of Change (ROC) is -2.44, creating a Sell signal.

FAQ

Is STX a Buy, Hold, or Sell?
Based on STX’s technical indicators, STX is a Hold.
    What is STX’s RSI (14)?
    STX’s RSI (14) is 42.43, which suggests STX is a Neutral.
      What is STX’s MACD?
      STX’s MACD is <0.01, which suggests STX is a Buy.
        What is STX’s 5-day moving average?
        STX’s 5-day moving average is 4.26, which suggests STX is a Sell.
          What is STX’s 20-day moving average?
          STX 20-day moving average is 4.40, which suggests STX is a Sell.
            What is STX’s 50-day moving average?
            STX’s 50-day moving average is 4.34, which suggests STX is a Sell.
              What is STX’s 200-day moving average?
              STX’s 200-day moving average is 3.20, which suggests STX is a Buy.
                What is STX’s Williams % R (14)?
                STX’s Williams % R (14) is -84.62, which suggests STX is a Buy.
                  What is STX’s CCI (14)?
                  STX’s CCI (14) is -126.15, which suggests STX is a Buy.
                    What is the share price of Shield Therapeutics PLC?
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis